Giuseppe graduated in Nuclear Physics at the University of Naples (Italy) in 1994 and obtained his PhD from King's College London (UK) in 1999, working on the development of ultrasoft X-ray microbeams for radiobiological applications. Following two postdoctoral experiences at the Gray Cancer Institute in the UK (2000-2004) and Center for Radiological Research at the Columbia University in New York (2004-2007), he worked as Lecturer at the Centre for Cancer Research and Cell Biology (CCRCB) of Queen's University Belfast from 2007 to 2013. In 2013, Giuseppe joined the Medical Radiation Physics Group at NPL as Principal Research Scientist. He has currently a joint position as Professor in Medical Physics at the University of Surrey (Department of Physics). Giuseppe is Chartered Physicist (CPhys) at the Institute of Physics and holds honorary senior lecturer positions at the Queen's University Belfast and the University College London. Giuseppe is also Editorial Board Member of Cancer Nanotechnology and Special Examiner for the Royal College of Radiologists.
Giuseppe Schettino is a Principal Research Scientist in the Medical Radiation Science Group at the NPL. His main research interest is in radiation biology, advanced radiotherapy and dosimetry. Current ongoing research activities are focused on dosimetry and radiobiology for MRI-based radiotherapy, biological effectiveness of proton and ion beams, use of gold nanoparticle as radio-sensitizers, definition of new dosimetry quantities closely related to biological response and biological optimization of treatment plans. He is also leading UK initiatives for standardization of dosimetry and QA processes for pre-clinical radiotherapy and radiobiology research. To date, he has published over 70 peer-reviewed papers (h-index 29).